Finasteride reduces the risk of prostate cancer

A new study published says the drug finasteride, used to treat urinary tract infections, has the potential to significantly reduce the risk of prostate cancer in men.

Illustration photo. (Source: sfgate.com)

According to research results by experts from the National Cancer Institute (USA), the use of the urinary tract treatment drug finasteride can reduce the risk of prostate cancer in men by up to 30%, while not promoting the growth of tumors and not increasing the risk of death of the patient.

A team of scientists led by Dr. Ian Thompson - a cancer treatment expert - conducted a multi-year study on more than 18,000 men aged 55 and over who used the drug finasteride. The results showed that only about 10% of those who used finasteride developed prostate cancer, while the rate of disease in those who did not use the drug was 15%.

Dr. Michael LeFevre, a member of the research team, said that using finasteride to treat urinary tract diseases in men is completely appropriate and does not cause serious side effects. However, according to him, users of this drug can fall into a state of fatigue, even weakness and significantly reduce sexual desire. Therefore, men need to consider carefully before deciding to use this drug.

In the US, each year about 240,000 people are diagnosed with prostate cancer, of which about 30,000 die. The results of this study may provide a new perspective on the use of cancer prevention drugs./.

According to VNA - M.D